T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
04/26/04	₩2,210.00	+0.45%	1,26,661
03/26/03	₩2,200.00	-0.68%	1,83,937
02/26/02	₩2,215.00	-2.64%	95,063
01/26/01	₩2,275.00	+0.44%	1,20,157
31/26/31	₩2,265.00	-4.23%	1,52,854

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 04/09/2026			5-day change	1st Jan Change
2,210.00 ^KRW	+0.45%		-7.53%	-43.48%

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/24/23	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	11TCr 7.82Cr 6.73Cr 6.33Cr 5.78Cr 11Cr 738.5Cr 11Cr 75Cr 29Cr 378.9Cr 29Cr 29Cr 1.22TCr	P/E 2024	-12.2x	P/E 2025	-3.91x
Enterprise Value	13TCr 9.43Cr 8.12Cr 7.64Cr 6.98Cr 13Cr 890.65Cr 13Cr 90Cr 35Cr 456.96Cr 35Cr 35Cr 1.47TCr	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	78.94%	Yield 2024 *	-	Yield 2025	-

21/01	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/24/23	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
05/24/05	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
23/24/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
04/24/04	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
25/24/25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
22/23/22	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
14/23/14	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
18/23/18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
04/23/04	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
26/23/26	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/23/15	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/21/20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+0.45%
1 week	-7.53%
Current month	-2.43%
1 month	-18.30%
3 months	+6.25%
6 months	-31.79%
Current year	-43.48%

T&R Biofab Co., Ltd. Share Price

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation : T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors : T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	2,150	2,365
1 month	2,150	3,025
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	30,958.33
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Jin-Hyung Shin CTO	Chief Tech/Sci/R&D Officer	41	-

Director	Title	Age	Since
Joo-Hyung Lee BRD	Director/Board Member	54	-
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/03/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
06/03/25	Eun-kyung Cho	Others		15,492	0.0719%
26/02/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+0.45%	-7.53%	-5.45%	-79.30%	7.72Cr
STRYKER CORPORATION	-1.58%	-8.33%	-23.13%	+6.57%	12TCr
SMITH & NEPHEW PLC	+1.14%	-0.79%	-23.40%	-0.05%	1.2TCr
GLAUKOS CORPORATION	-1.60%	-1.33%	+96.88%	+136.97%	1.06TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.47%	-0.35%	-50.14%	-70.18%	409.33Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+0.10%	-9.15%	-24.37%	+36.17%	247.81Cr
INSIGHT LIFETECH CO., LTD.	-1.76%	-6.83%	-	-	197.34Cr
INSPIRE MEDICAL SYSTEMS, INC.	+1.51%	+2.67%	-26.92%	-73.59%	179.65Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.67%	-4.14%	-19.33%	-24.68%	155.56Cr
Average	+0.16%	-1.96%	-9.48%	-8.51%	1.7TCr
Weighted average by Cap.	-1.17%	-5.23%	-15.44%	+12.32%

	2024	2025
Net sales	487.37Cr 36.19L 31.14L 29.3L 26.76L 50.07L 34Cr 50.21L 3.46Cr 1.34Cr 18Cr 1.36Cr 1.33Cr 56Cr	2.7TCr 2Cr 1.72Cr 1.62Cr 1.48Cr 2.77Cr 189.06Cr 2.78Cr 19Cr 7.43Cr 97Cr 7.52Cr 7.36Cr 312.49Cr
Net income	-767.88Cr -57.02L -49.06L -46.16L -42.17L -78.89L -54Cr -79.1L -5.45Cr -2.12Cr -28Cr -2.14Cr -2.09Cr -89Cr	-3.2TCr -2.37Cr -2.04Cr -1.92Cr -1.75Cr -3.28Cr -224Cr -3.29Cr -23Cr -8.81Cr -114.93Cr -8.91Cr -8.71Cr -370.24Cr
Net Debt	2.88TCr 2.14Cr 1.84Cr 1.73Cr 1.58Cr 2.96Cr 201.77Cr 2.96Cr 20Cr 7.93Cr 103.52Cr 8.02Cr 7.85Cr 333.5Cr	2.17TCr 1.61Cr 1.39Cr 1.3Cr 1.19Cr 2.23Cr 152.15Cr 2.24Cr 15Cr 5.98Cr 78Cr 6.05Cr 5.92Cr 251.48Cr